Table 4 Oxidant status in lung tissues (Mean ± SD).

From: Organ-protective effects of fullerenol and desflurane in a rat model of ischemia–reperfusion injury

 

S

n = 6

IR

n = 6

IR-FUL

n = 6

IR-DES

n = 6

IR-FUL-DES

n = 6

p**

TBARS (nmol/mg pr)

0.29 ± 0.07

1.12 ± 0.10*

0.38 ± 0.05+

0.61 ± 0.13+

0.42 ± 0.06+

< 0.0001

CAT (IU/mg pr)

63.83 ± 11.28

27.40 ± 7.24*

53.23 ± 4.76+

40.28 ± 6.40*

48.67 ± 9.20+

< 0.0001

GST (IU/mg pr)

0.97 ± 0.21

0.31 ± 0.10*

0.88 ± 0.30+

0.65 ± 0.20

0.79 ± 0.13+

< 0.0001

ARE (IU/mg pr)

1.29 ± 0.30

0.29 ± 0.09*

1.06 ± 0.15+

0.74 ± 0.22*,+

0.89 ± 0.19*,+

< 0.0001

  1. p**: ANOVA test significance level p < 0.05. *p < 0.05: Compared to the Group Sham. + p < 0.005: Compared to Group IR. TBARS, thiobarbituric acid reactive substances; CAT, catalase; Glutathione S-transferase (GST); ARE, arylesterase. IR; ischemia reperfusion; IR-FUL, Fullerenol C60-IR; IR-DES, IR-Desflurane; IR-FUL-DES, Fullerenol C60 -IR- Desflurane.